- Active not recruitingPHASE1
Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
The Honeycomb study is testing a new medicine called Radiprodil for children aged 6 months to 12 years with a specific genetic condition called GRIN-related disorder. The study aims to see if Radiprodil is safe, how the body handles it, and if it could help children with this condition.
For: GRIN-related DisordersUnited States · Australia · Canada - RecruitingPHASE3
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
This study, called Beeline, is looking at a new medicine called radiprodil for children and young people with a condition called GRIN-related neurodevelopmental disorder (GRIN-NDD). It wants to see if the medicine helps with seizures and other symptoms, and if it's safe.
For: GRIN-related Neurodevelopmental DisorderUnited States · Belgium · France - Active not recruitingPHASE1, PHASE2
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
This study, called Astroscape, is testing a new medicine called radiprodil for children and young people aged 6 months to 18 years. It's for those with Tuberous Sclerosis Complex (TSC) or Focal Cortical Dysplasia (FCD Type II) who experience difficult-to-treat seizures.
For: Tuberous Sclerosis Complex · Focal Cortical DysplasiaAustralia · Belgium · Canada